This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutman, A
Right arrow Articles by Wasylyk, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutman, A
Right arrow Articles by Wasylyk, B

 Previous Article

Mol Cell Biol. 1991 October; 11(10): 5381-5387

Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter.

A Gutman, C Wasylyk and B Wasylyk

Laboratoire de Génétique Moleculaire des Eucaryotes, Faculté de Médecine, Strasbourg, France.

ABSTRACT

We have identified oncogene-responsive sequences in the human c-fos promoter that mediate induction of transcription by several nonnuclear oncoproteins and the tumor promoter TPA. These sequences are regulated in a cell-specific manner. (i) In NIH 3T3 cells, the CArG box of the c-fos promoter is sufficient to mediate activation by oncogenes. (ii) In contrast, in HeLa cells, additional flanking sequences are also required, including the outer arm of the serum response element and the FAP site. We also show that the serum response factor, which binds to the CArG box, activates transcription in vivo in NIH 3T3 cells but not in HeLa cells. Finally, we present evidence that the intracellular level of the c-Fos protein could be a major determinant of cell-specific regulation of these oncogene-responsive elements of the c-fos promoter.


Mol Cell Biol. 1991 October; 11(10): 5381-5387




This article has been cited by other articles:

  • Doherty, J., Freund, R. (1999). Middle T Antigen Activation of Signal Transduction Pathways Does Not Overcome p53-Mediated Growth Arrest. J. Virol. 73: 7882-7885 [Abstract] [Full Text]  
  • Heidenreich, O., Neininger, A., Schratt, G., Zinck, R., Cahill, M. A., Engel, K., Kotlyarov, A., Kraft, R., Kostka, S., Gaestel, M., Nordheim, A. (1999). MAPKAP Kinase 2 Phosphorylates Serum Response Factor in Vitro and in Vivo. J. Biol. Chem. 274: 14434-14443 [Abstract] [Full Text]  
  • Bradford, A. P., Conrad, K. E., Tran, P. H., Ostrowski, M. C., Gutierrez-Hartmann, A. (1996). GHF-1/Pit-1 Functions as a Cell-specific Integrator of Ras Signaling by Targeting the Ras Pathway to a Composite Ets-1/GHF-1 Response Element. J. Biol. Chem. 271: 24639-24648 [Abstract] [Full Text]  
  • Spencer, J. A., Misra, R. P. (1996). Expression of the Serum Response Factor Gene Is Regulated by Serum Response Factor Binding Sites. J. Biol. Chem. 271: 16535-16543 [Abstract] [Full Text]  
  • Chen, Y.-Q., Gilliam, D. M., Rydzewski, B., Naftilan, A. J. (1996). Multiple Enhancer Elements Mediate Induction of c-fos in Vascular Smooth Muscle Cells. Hypertension 27: 1224-1233 [Abstract] [Full Text]  
  • Simonson, M. S., Wang, Y., Herman, W. H. (1996). Nuclear Signaling by Endothelin-1 Requires Src Protein-tyrosine Kinases. J. Biol. Chem. 271: 77-82 [Abstract] [Full Text]  
  • Grugel, S., Finkenzeller, Gün., Weindel, K., Barleon, B., Marmé, D. (1995). Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells. J. Biol. Chem. 270: 25915-25919 [Abstract] [Full Text]  
  • Nilsson, M., Toftg, R., Bohm, S. (1995). Activated Ha-Ras but Not TPA Induces Transcription through Binding Sites for Activating Transcription Factor 3/Jun and a Novel Nuclear Factor. J. Biol. Chem. 270: 12210-12218 [Abstract] [Full Text]  
  • Rech, J, Barlat, I, Veyrune, J., Vie, A, Blanchard, J. (1994). Nuclear import of serum response factor (SRF) requires a short amino-terminal nuclear localization sequence and is independent of the casein kinase II phosphorylation site. J. Cell Sci. 107: 3029-3036 [Abstract]